Key Insights The projected fair value for Becton Dickinson is US$330 based on 2 Stage Free Cash Flow to Equity ...

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of ...

One company to watch right now is Becton, Dickinson and Company (BDX). BDX is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with P/E ratio of 15.73 ...

Partnership signed on the sidelines of Global Health Saudi 2024; aims to drive patient safety, reduce medication errors, and ...

Capital Performance Advisors LLP bought a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) in ...

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $280.00. The company’s shares opened today at $226.95. Wise covers ...

Q4 2024 Earnings Call Transcript November 7, 2024 Operator: Hello and welcome to BD’s Fourth Quarter and Full Year Fiscal ...

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.81 in the fourth ...

BDX currently has a forward P/E ratio of 16.78, while MMSI has a forward P/E of 30.58. We also note that BDX has a PEG ratio of 1.80. This popular metric is similar to the widely-known P/E ratio, with ...

Dubai, United Arab Emirates, November 06, 2024 – The Dubai branch of BD (Becton, Dickinson, and Company) (NYSE: BDX), one of the leading global medic ...

BD (NYSE:BDX) shares ticked up before hours today on fourth-quarter results that came in ahead of the consensus forecast.